Cui H, Kilpeläinen T, Zouzoula L, Auno S, Trontti K, Kurvonen S, et al. Prolyl oligopeptidase inhibition reduces alpha-synuclein aggregation in a cellular model of multiple system atrophy. J Cell Mol Med. 2021;25:9634-9646 pubmed publisher

Julku U, Jäntti M, Svarcbahs R, Myöhänen T. Prolyl Oligopeptidase Regulates Dopamine Transporter Oligomerization and Phosphorylation in a PKC- and ERK-Independent Manner. Int J Mol Sci. 2021;22: pubmed publisher

Bäck S, Dossat A, Parkkinen I, Koivula P, Airavaara M, Richie C, et al. Neuronal Activation Stimulates Cytomegalovirus Promoter-Driven Transgene Expression. Mol Ther Methods Clin Dev. 2019;14:180-188 pubmed publisher

Bäck S, Necarsulmer J, Whitaker L, Coke L, Koivula P, Heathward E, et al. Neuron-Specific Genome Modification in the Adult Rat Brain Using CRISPR-Cas9 Transgenic Rats. Neuron. 2019;102:105-119.e8 pubmed publisher

Svarcbahs R, Julku U, Norrbacka S, Myöhänen T. Removal of prolyl oligopeptidase reduces alpha-synuclein toxicity in cells and in vivo. Sci Rep. 2018;8:1552 pubmed publisher

Savolainen M, Richie C, Harvey B, Mannisto P, Maguire Zeiss K, Myöhänen T. The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse. Neurobiol Dis. 2014;68:1-15 pubmed publisher